Valeant Pharmaceuticals International today announced that it has acquired DermaTech Pty Ltd, an Australian specialty pharmaceutical company focused on dermatology products marketed throughout Australia and overseas, for approximately AU$19 million, with customary adjustments for net asset value.
Valeant Pharmaceuticals acquires DermaTech